BIOVECTRA
BioVectra manufactures ingredients for global pharmaceutical and biotechnology clients offering therapeutics used in the treatment of cancer, kidney disease, cardio-vascular disease, multiple sclerosis, and many other serious diseases. With over 40 years experience, the company is proficient in synthetic organic chemistry, fermentation of chemical and biologic molecules, downstream processing, MPEG production, and conjugation chemistry. BioVectra was founded on 1970 and is based in Charlottetown, Canada.
BIOVECTRA
Industry:
Biotechnology Health Care Manufacturing Therapeutics
Founded:
1970-01-01
Address:
Charlottetown, Prince Edward Island, Canada
Country:
Canada
Website Url:
http://www.biovectra.com
Total Employee:
251+
Status:
Active
Contact:
866.883.2872
Total Funding:
77.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Anika Therapeutics
Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its
Applikon Biotechnology
A world leader in developing and supplying advanced bioreactor systems from laboratory scale to production scale.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Biomeasure
Biomeasure is a developer of non-invasive health assesment tools.
Celltrion
Celltrion engaged in the research, development, and manufacture of therapeutic proteins.
Chemo Iberica
Chemo Iberica, S.A. manufactures and distributes generic medicines. It offers pharmaceuticals; agrochemicals, including insecticides,
Cytovance Biologics
Cytovance Biologics produces therapeutic proteins and antibodies from mammalian cell cultures and microbial fermentations.
Encube Ethicals
Encube Ethicals a contract development and manufacturing organization, specializes in topical semisolid formulations.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Greatbatch
Greatbatch, Inc. (Greatbatch) is developer and manufacturer of components for implantable medical devices (IMDs) and Electrochem batteries
Kindeva Drug Delivery
Kindeva Drug Delivery is a global contract development and manufacturing organization (CDMO) in the pharmaceutical industry.
Microdermis
Microdermis manufactures and markets skin care products for skin repair and protection, antimicrobial, and dental skin care.
Nova Biomedical
Nova Biomedical provides advanced technology blood testing analyzers, based on electrochemical and optical measuring techniques.
OPK Biotech
OPK Biotech develops, manufactures and markets oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to
OsteoBiologics
OsteoBiologics engages in the development and manufacture of bioabsorbable polymeric scaffolds, films, and related instrumentations.
Simcere Pharma
Simcere Pharma is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market.
Solid State Cooling Systems
Systems engineers thermal management solutions for laser, laboratory, medical and biopharmaceutical and the semiconductor industry.
Bio-Techne
Bio-Techne is a supplier of high quality and innovative tools for Life Science Research, Therapeutic Manufacturing and Clinical Diagnostics.
Trio Healthcare
Trio Healthcare International manufactures and markets products for ostomy, wounds, and other continence issues.
Viamed
Viamed focuses on the development, manufacture and distribution of innovative medical products.
Vibalogics
Vibalogics is a contract development and manufacturing organization focused on complex live biological products.
YposKesi
Yposkesi is a European Contract Development & Manufacturing Organization (CDMO) for Gene and Cell Therapy - Lentivirus & AAV viral vectors.
Current Advisors List
Board_member
2019-01-01
Current Employees Featured
Heather Delage Chief Commercial Officer @ BioVectra
Chief Commercial Officer
2020-09-01
Scott Doncaster Vice President, Manufacturing Technologies and Engineering @ BioVectra
Vice President, Manufacturing Technologies and Engineering
1995-11-01
Oliver Technow Chief Executive Officer @ BioVectra
Chief Executive Officer
2019-11-01
Regis Duffy Founder @ BioVectra
Founder
Marc Sauer Chief Science Officer @ BioVectra
Chief Science Officer
2022-04-01
David Long Chief Financial Officer @ BioVectra
Chief Financial Officer
2020-11-01
Ted Dolan Chief Operating Officer @ BioVectra
Chief Operating Officer
Founder
Investors List
Government of Canada
Government of Canada investment in Grant - BioVectra
Strategic Innovation Fund (SIF)
Strategic Innovation Fund (SIF) investment in Grant - BioVectra
Official Site Inspections
http://www.biovectra.com Semrush global rank: 2.07 M Semrush visits lastest month: 10.12 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "BioVectra"
Biologics, API & Drug Development CDMO | BIOVECTRA
Jan 26, 2023 BIOVECTRA is a North American CDMO specializing in clinical-to-commercial scale production capabilities for: Biologics; Synthetic small molecules; ... Bold vision, along with the passion and commitment to make that vision a …See details»
Agilent Technologies to Acquire BIOVECTRA Inc., Creating New ...
Jul 22, 2024 BIOVECTRA (www.biovectra.com) is a global biotech and pharmaceutical CDMO (contract development and manufacturing organization) that specializes in clinical-to …See details»
BIOVECTRA Profile | The Scientist
Mar 17, 2025 BIOVECTRA is a part of Agilent, a leader in clinical and analytical lab technologies and specialized CDMO services. With operations in Atlantic Canada, BIOVECTRA specializes …See details»
BioVectra Inc. - BioTalent Canada
Mar 22, 2025 BioVectra is a Contract Development and Manufacturing Organization (CDMO) that serves global pharmaceutical and biotech companies with full-service cGMP outsourcing …See details»
BioVectra - Crunchbase Company Profile & Funding
Sub-Organization of . Mallinckrodt . Founded Date 1970; Founders Regis Duffy; Operating Status Active; Last Funding Type Grant; Legal Name BioVectra Inc. ... BioVectra was founded on 1970 and is based in Charlottetown, Canada. Read …See details»
BIOVECTRA: a success story in the burgeoning PEI …
Sep 5, 2024 BIOVECTRA, a contract development manufacturing organization which counts 19 of the world’s top 20 pharmaceutical companies among its clients, is now a leader in the bioscience cluster both in the region and in …See details»
Agilent Completes Acquisition of BIOVECTRA
Sep 20, 2024 Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and …See details»
BioVectra Company Profile - Office Locations, Competitors ... - Craft
BioVectra is a biotech and pharmaceutical contract development and manufacturing organization (CDMO). It provides project support services such as rapid process development and …See details»
BIOVECTRA acquired for $925 million - Springboard Atlantic (New)
Jul 23, 2024 BIOVECTRA Inc. and Agilent Technologies, Inc. (NYSE: A) announced the signing of an agreement for Agilent to acquire BIOVECTRA, a Canadian-based Contract Development …See details»
Contact Us - BIOVECTRA
Appointed President of BIOVECTRA Inc., December 10, 2015. Board Director for BIOTECanada; Member of the Steering Council of Innovative Medicines Canada (IMC) In 2017, appointed to the Government of Canada’s Health/Bio-sciences …See details»
BioVectra 2025 Company Profile: Valuation, Investors ... - PitchBook
BioVectra was founded in 1970. Where is BioVectra headquartered? BioVectra is headquartered in Charlottetown, Canada. What is the size of BioVectra? BioVectra has 582 total employees. …See details»
Agilent to Acquire North American CDMO BIOVECTRA
Jul 22, 2024 BIOVECTRA (www.biovectra.com) is a global biotech and pharmaceutical CDMO (contract development and manufacturing organization) that specializes in clinical-to …See details»
BIOVECTRA - LinkedIn
BIOVECTRA | 17,841 followers on LinkedIn. A global, full-service CDMO specializing in biologics, small molecules, pDNA/mRNA manufacturing, HPAPIs, & bioreagents. | Expertise in both …See details»
BioVectra | H.I.G. Healthbridge - H.I.G. BioHealth Partners
BioVectra (Active investment within the Business Services, Chemicals, Healthcare sector) was a 2019 investment through the Biohealth fund strategy. ... is a leading contract development and …See details»
Come Home to BioVectra - Pharma's Almanac
May 24, 2019 BioVectra is a Canadian contract development and manufacturing organization with nearly 50 years of experience supporting global pharmaceutical and biotech companies in …See details»
BIOVECTRA Information - RocketReach
Bold vision, along with the passion and commitment to make that vision a reality, is at the heart of our organization. We are a forward-thinking, North American CDMO Pharmaceutical company …See details»
Agilent to Acquire North American CDMO BIOVECTRA
Jul 22, 2024 BIOVECTRA (www.biovectra.com) is a global biotech and pharmaceutical CDMO (contract development and manufacturing organization) that specializes in clinical-to …See details»
BioVectra - PharmaSource
BIOVECTRA is a global biotech and pharmaceutical contract development and manufacturing organisation (CDMO) that specializes in clinical-to-commercial scale production capabilities for …See details»
BIOVECTRA Named One of Canada’s Top Employers Again in 2023
Nov 22, 2022 Charlottetown, P.E.I. (November 22, 2022) – BIOVECTRA was selected as one of Canada’s Top 100 Employers for a second consecutive year and is considered amongst the …See details»
Agilent’s integration of recently acquired Biovectra remains a work …
Mar 24, 2025 Six months after Agilent Technologies completed its $925 million acquisition of Biovectra, a Canadian contract development and manufacturing organization (CDMO), the …See details»